321 related articles for article (PubMed ID: 10612717)
1. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus. Measurements with a new immunoprecipitation assay.
Masuda M; Powell M; Chen S; Beer C; Fichna P; Rees Smith B; Furmaniak J
Clin Chim Acta; 2000 Jan; 291(1):53-66. PubMed ID: 10612717
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus.
Pietropaolo M; Peakman M; Pietropaolo SL; Zanone MM; Foley TP; Becker DJ; Trucco M
J Autoimmun; 1998 Feb; 11(1):1-10. PubMed ID: 9480718
[TBL] [Abstract][Full Text] [Related]
3. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
4. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
Kawasaki E; Eisenbarth GS; Wasmeier C; Hutton JC
Diabetes; 1996 Oct; 45(10):1344-9. PubMed ID: 8826969
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
7. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
Li Q; Borovitskaya AE; DeSilva MG; Wasserfall C; Maclaren NK; Notkins AL; Lan MS
Proc Assoc Am Physicians; 1997 Jul; 109(4):429-39. PubMed ID: 9220540
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.
Morgenthaler NG; Seissler J; Achenbach P; Glawe D; Payton M; Meinck HM; Christie MR; Scherbaum WA
Autoimmunity; 1997; 25(4):203-11. PubMed ID: 9344328
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
10. Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM.
Genovese S; Bonfanti R; Bazzigaluppi E; Lampasona V; Benazzi E; Bosi E; Chiumello G; Bonifacio E
Diabetologia; 1996 Oct; 39(10):1223-6. PubMed ID: 8897011
[TBL] [Abstract][Full Text] [Related]
11. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.
Lan MS; Wasserfall C; Maclaren NK; Notkins AL
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6367-70. PubMed ID: 8692821
[TBL] [Abstract][Full Text] [Related]
12. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
Savola K; Bonifacio E; Sabbah E; Kulmala P; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Meriläinen J; Akerblom HK; Knip M
Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346
[TBL] [Abstract][Full Text] [Related]
13. Recombinant IA-2 expressed in E. coli can be used for the routine detection of autoantibodies in Type-I diabetes.
Morgenthaler NG; Löbner K; Morgenthaler UY; Christie MR; Seissler J; Scherbaum WA
Horm Metab Res; 1998 Sep; 30(9):559-64. PubMed ID: 9808324
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
Borg H; Fernlund P; Sundkvist G
Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455
[TBL] [Abstract][Full Text] [Related]
15. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
[TBL] [Abstract][Full Text] [Related]
16. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
17. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM.
Feeney SJ; Myers MA; Mackay IR; Zimmet PZ; Howard N; Verge CF; Rowley MJ
Diabetes Care; 1997 Sep; 20(9):1403-7. PubMed ID: 9283787
[TBL] [Abstract][Full Text] [Related]
19. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
Sera Y; Kawasaki E; Abiru N; Ozaki M; Abe T; Takino H; Kondo H; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S; Uchigata Y; Matsuura N; Eguchi K
J Autoimmun; 1999 Sep; 13(2):257-65. PubMed ID: 10479394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
